MedTrace Logo

LV Endocardial CRT for Patients With Intermediate QRS Width

NCT03573427 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-07-24

No results posted yet for this study

Summary

This pilot study is designed as a multi-centre cohort study determining the degree of LV reverse remodeling in patients with intermediate QRS widths (120-149ms) who undergo CRT implant with transseptal LV leads, and comparing to the average expected reverse remodeling rate in patients with standard transvenous coronary sinus leads and QRS widths ≥150ms.

Conditions

  • Heart Failure，Congestive
  • Left Ventricular Dysfunction
  • Left Bundle-Branch Block

Interventions

DEVICE

Trans-atrial septal placement LV lead for CRT

Sponsors & Collaborators

  • Jaimie Manlucu

    lead OTHER

Principal Investigators

  • Jaimie Manlucu, MD FRCPC · Schulich School of Medicine, Western University, London Health Sciences Centre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-28
Primary Completion
2019-04-28
Completion
2019-07-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03573427 on ClinicalTrials.gov